-
1
-
-
78650454230
-
Add-on therapies to metformin for type 2 diabetes
-
Shomali M. Add-on therapies to metformin for type 2 diabetes. Expert Opin Pharmacother. 2011;12(1):47-62.
-
(2011)
Expert Opin Pharmacother
, vol.12
, Issue.1
, pp. 47-62
-
-
Shomali, M.1
-
2
-
-
0036483958
-
Sulfonylurea inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)
-
Wright A, Burden AC, Paisey RB, Cull CA, Holman RR. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57). Diabetes Care. 2002;25(2):330-336.
-
(2002)
Diabetes Care
, vol.25
, Issue.2
, pp. 330-336
-
-
Wright, A.1
Burden, A.C.2
Paisey, R.B.3
Cull, C.A.4
Holman, R.R.5
-
3
-
-
84864285795
-
Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
-
Inzucchi SE, Bergenstal RM, Buse JB, etal. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55(6):1577-1596.
-
(2012)
Diabetologia
, vol.55
, Issue.6
, pp. 1577-1596
-
-
Inzucchi, S.E.1
Bergenstal, R.M.2
Buse, J.B.3
-
4
-
-
84855185039
-
Standards of medical care in diabetes-2012
-
American Diabetes Association (ADA)
-
American Diabetes Association (ADA). Standards of medical care in diabetes-2012. Diabetes Care. 2012;35 Suppl 1:S11-S63.
-
(2012)
Diabetes Care
, vol.35
, Issue.SUPPL. 1
-
-
-
5
-
-
80053385824
-
Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: A 6-month 'proof-of-concept' study
-
Owens DR, Luzio SD, Sert-Langeron C, Riddle MC. Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study. Diabetes Obes Metab. 2011;13(11): 1020-1027.
-
(2011)
Diabetes Obes Metab
, vol.13
, Issue.11
, pp. 1020-1027
-
-
Owens, D.R.1
Luzio, S.D.2
Sert-Langeron, C.3
Riddle, M.C.4
-
6
-
-
12844265257
-
Initiating insulin therapy in type 2 diabetes: A comparison of biphasic and basal insulin analogs
-
Raskin P, Allen E, Hollander P, etal. Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care. 2005;28(2):260-265.
-
(2005)
Diabetes Care
, vol.28
, Issue.2
, pp. 260-265
-
-
Raskin, P.1
Allen, E.2
Hollander, P.3
-
7
-
-
33846254561
-
Basal insulin or premix analogue therapy in type 2 diabetes patients
-
Raskin PR, Hollander PA, Lewin A, Gabbay RA, Bode B, Garber AJ. Basal insulin or premix analogue therapy in type 2 diabetes patients. Eur J Intern Med. 2007;18(1):56-62.
-
(2007)
Eur J Intern Med
, vol.18
, Issue.1
, pp. 56-62
-
-
Raskin, P.R.1
Hollander, P.A.2
Lewin, A.3
Gabbay, R.A.4
Bode, B.5
Garber, A.J.6
-
8
-
-
79958062820
-
Utilities and disutilities for attributes of injectable treatments for type 2 diabetes
-
Boye KS, Matza LS, Walter KN, Van Brunt K, Palsgrove AC, Tynan A. Utilities and disutilities for attributes of injectable treatments for type 2 diabetes. Eur J Health Econ. 2011;12(3):219-230.
-
(2011)
Eur J Health Econ
, vol.12
, Issue.3
, pp. 219-230
-
-
Boye, K.S.1
Matza, L.S.2
Walter, K.N.3
Van Brunt, K.4
Palsgrove, A.C.5
Tynan, A.6
-
9
-
-
77951047546
-
Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs
-
Peyrot M, Rubin RR, Polonsky WH, Best JH. Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs. Curr Med Res Opin. 2010;26(5):1047-1054.
-
(2010)
Curr Med Res Opin
, vol.26
, Issue.5
, pp. 1047-1054
-
-
Peyrot, M.1
Rubin, R.R.2
Polonsky, W.H.3
Best, J.H.4
-
10
-
-
73349140858
-
Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study
-
Fritsche A, Larbig M, Owens D, Häring HU. Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study. Diabetes Obes Metab. 2010;12(2):115-123.
-
(2010)
Diabetes Obes Metab
, vol.12
, Issue.2
, pp. 115-123
-
-
Fritsche, A.1
Larbig, M.2
Owens, D.3
Häring, H.U.4
-
11
-
-
35548947584
-
Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes
-
Holman RR, Thorne KI, Farmer AJ, etal. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med. 2007;357(17):1716-1730.
-
(2007)
N Engl J Med
, vol.357
, Issue.17
, pp. 1716-1730
-
-
Holman, R.R.1
Thorne, K.I.2
Farmer, A.J.3
-
12
-
-
70350534273
-
Three-year efficacy of complex insulin regimens in type 2 diabetes
-
Holman RR, Farmer AJ, Davies MJ, etal. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med. 2009;361(18): 1736-1747.
-
(2009)
N Engl J Med
, vol.361
, Issue.18
, pp. 1736-1747
-
-
Holman, R.R.1
Farmer, A.J.2
Davies, M.J.3
-
13
-
-
39449106869
-
Efficacy and treatment satisfaction of once-daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with type 2 diabetes previously on long-term conventional insulin therapy: The SWITCH Pilot Study
-
Schiel R, Müller UA. Efficacy and treatment satisfaction of once-daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with type 2 diabetes previously on long-term conventional insulin therapy: the SWITCH Pilot Study. Exp Clin Endocrinol Diabetes. 2008;116(1):58-64.
-
(2008)
Exp Clin Endocrinol Diabetes
, vol.116
, Issue.1
, pp. 58-64
-
-
Schiel, R.1
Müller, U.A.2
-
14
-
-
84865067095
-
Resource utilisation and clinical data before and after switching between short-acting human insulin and rapid-acting insulin analogues in patients with type 2 diabetes: The SWING study
-
Reaney M, Cypryk K, Tentolouris N, etal. Resource utilisation and clinical data before and after switching between short-acting human insulin and rapid-acting insulin analogues in patients with type 2 diabetes: the SWING study. Diabetes Res Clin Pract. 2012;97(2):231-241.
-
(2012)
Diabetes Res Clin Pract
, vol.97
, Issue.2
, pp. 231-241
-
-
Reaney, M.1
Cypryk, K.2
Tentolouris, N.3
-
15
-
-
38349101301
-
Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies
-
Davies M, Sinnassamy P, Storms F, Gomis R. Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies. Diabetes Res Clin Pract. 2008;79(2):368-375.
-
(2008)
Diabetes Res Clin Pract
, vol.79
, Issue.2
, pp. 368-375
-
-
Davies, M.1
Sinnassamy, P.2
Storms, F.3
Gomis, R.4
-
16
-
-
84877738609
-
Are current clinical trials in diabetes addressing important issues in diabetes care?
-
Lakey WC, Barnard K, Batch BC, Chiswell K, Tasneem A, Green JB. Are current clinical trials in diabetes addressing important issues in diabetes care? Diabetologia. 2013;56(6):1226-1235.
-
(2013)
Diabetologia
, vol.56
, Issue.6
, pp. 1226-1235
-
-
Lakey, W.C.1
Barnard, K.2
Batch, B.C.3
Chiswell, K.4
Tasneem, A.5
Green, J.B.6
-
17
-
-
0034702175
-
Randomized, controlled trials, observational studies, and the hierarchy of research designs
-
Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25):1887-1892.
-
(2000)
N Engl J Med
, vol.342
, Issue.25
, pp. 1887-1892
-
-
Concato, J.1
Shah, N.2
Horwitz, R.I.3
-
18
-
-
35948970944
-
Patients with type 2 diabetes inadequately controlled on premixed insulin: Effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice
-
Hammer H, Klinge A. Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice. Int J Clin Pract. 2007;61(12):2009-2018.
-
(2007)
Int J Clin Pract
, vol.61
, Issue.12
, pp. 2009-2018
-
-
Hammer, H.1
Klinge, A.2
-
19
-
-
61649113766
-
Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: A retrospective primary-care-based analysis
-
Sharplin P, Gordon J, Peters JR, Tetlow AP, Longman AJ, McEwan P. Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis. Cardiovasc Diabetol. 2009;8:9.
-
(2009)
Cardiovasc Diabetol
, vol.8
, pp. 9
-
-
Sharplin, P.1
Gordon, J.2
Peters, J.R.3
Tetlow, A.P.4
Longman, A.J.5
McEwan, P.6
-
20
-
-
84862686725
-
Optimization of insulin therapy in patients with type 2 diabetes mellitus: Beyond basal insulin
-
Blak BT, Smith HT, Hards M, Curtis BH, Ivanyi T. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin. Diabet Med. 2012;29(7):e13-e20.
-
(2012)
Diabet Med
, vol.29
, Issue.7
-
-
Blak, B.T.1
Smith, H.T.2
Hards, M.3
Curtis, B.H.4
Ivanyi, T.5
-
21
-
-
77953027133
-
Assessment of adherence and healthcare costs costs of insulin device (FlexPen®) versus conventional vial/syringe
-
Baser O, Bouchard J, DeLuzio T, Henk H, Aagren M. Assessment of adherence and healthcare costs costs of insulin device (FlexPen®) versus conventional vial/syringe. Adv Ther. 2010;27(2):94-104.
-
(2010)
Adv Ther
, vol.27
, Issue.2
, pp. 94-104
-
-
Baser, O.1
Bouchard, J.2
DeLuzio, T.3
Henk, H.4
Aagren, M.5
-
22
-
-
84884714255
-
-
National Committee for Quality Assurance, Available from, Accessed July 19 2013
-
National Committee for Quality Assurance. HEDIS 2013. Available from: http://www.ncqa.org/HEDISQualityMeasurement/HEDISMeasures/HEDIS2013.aspx. Accessed July 19, 2013.
-
HEDIS 2013
-
-
-
23
-
-
77955096791
-
Validating ICD coding algorithms for diabetes mellitus from administrative data
-
Chen G, Khan N, Walker R, Quan H. Validating ICD coding algorithms for diabetes mellitus from administrative data. Diabetes Res Clin Pract. 2010;89(2):189-195.
-
(2010)
Diabetes Res Clin Pract
, vol.89
, Issue.2
, pp. 189-195
-
-
Chen, G.1
Khan, N.2
Walker, R.3
Quan, H.4
-
24
-
-
84855846339
-
Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care setting
-
Davis SN, Wei W, Garg S. Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care setting. Endocr Pract. 2011;17(6): 845-852.
-
(2011)
Endocr Pract
, vol.17
, Issue.6
, pp. 845-852
-
-
Davis, S.N.1
Wei, W.2
Garg, S.3
-
25
-
-
84875205714
-
Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus
-
Xie L, Zhou S, Wei W, Gill J, Pan C, Baser O. Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus. Diabetes Technol Ther. 2013;15(3):230-236.
-
(2013)
Diabetes Technol Ther
, vol.15
, Issue.3
, pp. 230-236
-
-
Xie, L.1
Zhou, S.2
Wei, W.3
Gill, J.4
Pan, C.5
Baser, O.6
-
26
-
-
82355180949
-
A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens
-
Xie L, Wei W, Pan C, Du J, Baser O. A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens. Adv Ther. 2011;28(11):1000-1011.
-
(2011)
Adv Ther
, vol.28
, Issue.11
, pp. 1000-1011
-
-
Xie, L.1
Wei, W.2
Pan, C.3
Du, J.4
Baser, O.5
-
27
-
-
81255124243
-
Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BID
-
Baser O, Wei W, Baser E, Xie L. Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BID. J Med Econ. 2011;14(6):673-680.
-
(2011)
J Med Econ
, vol.14
, Issue.6
, pp. 673-680
-
-
Baser, O.1
Wei, W.2
Baser, E.3
Xie, L.4
-
28
-
-
84863230184
-
Combination therapy with insulin glargine and exenatide: Real-world outcomes in patients with type 2 diabetes
-
Levin P, Wei W, Wang L, Pan C, Douglas D, Baser O. Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes. Curr Med Res Opin. 2012;28(3): 439-446.
-
(2012)
Curr Med Res Opin
, vol.28
, Issue.3
, pp. 439-446
-
-
Levin, P.1
Wei, W.2
Wang, L.3
Pan, C.4
Douglas, D.5
Baser, O.6
-
29
-
-
84862108594
-
Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes
-
Zhao Y, Campbell CR, Fonseca V, Shi L. Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes. Diabetes Care. 2012;35(5):1126-1132.
-
(2012)
Diabetes Care
, vol.35
, Issue.5
, pp. 1126-1132
-
-
Zhao, Y.1
Campbell, C.R.2
Fonseca, V.3
Shi, L.4
-
30
-
-
77951622706
-
The central role of the propensity score in observational studies for causal effects
-
Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1): 41-55.
-
(1983)
Biometrika
, vol.70
, Issue.1
, pp. 41-55
-
-
Rosenbaum, P.R.1
Rubin, D.B.2
-
31
-
-
38549098101
-
Medication compliance and persistence: Terminology and definitions
-
Cramer JA, Roy A, Burrell A, etal. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1): 44-47.
-
(2008)
Value Health
, vol.11
, Issue.1
, pp. 44-47
-
-
Cramer, J.A.1
Roy, A.2
Burrell, A.3
-
32
-
-
84886087279
-
Patient reported outcomes using twice-daily insulin aspart premixed vs insulin glargine plus 1 prandial insulin glulisine or step-wise addition of glulisine to glargine in type 2 diabetes uncontrolled with oral agents [abstract]
-
Polonsky WH, Rosenstock J, Gilmore AS, Wei W, Chaudhs SL, Riddle MC. Patient reported outcomes using twice-daily insulin aspart premixed vs insulin glargine plus 1 prandial insulin glulisine or step-wise addition of glulisine to glargine in type 2 diabetes uncontrolled with oral agents [abstract]. Diabetes. 2011;60 Suppl 1:A616.
-
(2011)
Diabetes
, vol.60
, Issue.SUPPL. 1
-
-
Polonsky, W.H.1
Rosenstock, J.2
Gilmore, A.S.3
Wei, W.4
Chaudhs, S.L.5
Riddle, M.C.6
-
33
-
-
78349266799
-
A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: An observational database study
-
Gordon J, Pockett RD, Tetlow AP, McEwan P, Home PD. A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study. Int J Clin Pract. 2010;64(12):1609-1618.
-
(2010)
Int J Clin Pract
, vol.64
, Issue.12
, pp. 1609-1618
-
-
Gordon, J.1
Pockett, R.D.2
Tetlow, A.P.3
McEwan, P.4
Home, P.D.5
-
35
-
-
38449093271
-
Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: An evidence-based comparison
-
Ilag LL, Kerr L. Malone JK, Tan MH. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison. Clin Ther. 2007;29(6 Pt 1):1254-1270.
-
(2007)
Clin Ther
, vol.29
, Issue.6 PART 1
, pp. 1254-1270
-
-
Ilag, L.L.1
Kerr, L.2
Malone, J.K.3
Tan, M.H.4
|